All you armchair quarterbacks emailing NP should d
Post# of 145836
![](/assets/46931549/no_avatar_available_thumb.jpg)
These articles are meaningless. Institutions aren’t *not* buying bc of a paid article. They’re not buying because we’re on the OTC and trading at a buck. The alternative here is for NP to just stay completely silent until results push us over $2 and/or we have the revenue to uplist.
I don’t care about typos (as annoying as they are). I care about BLA, BTD, and how our CV patients are doing.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)